Palmoplantar Pustular Psoriasis Efficacy and Safety With Secukinumab
Clinical trial NCT02008890 · COMPLETED
Trial details
- NCT number
- NCT02008890
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-26
- Primary completion
- 2014-11-24
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.